Hospital Infections

Child's patient hand with saline intravenous drip

HOSPITAL INFECTIONS

Treatment of Hospital infections in the US account for about $10 billion in annual healthcare expenditures. Gram-positive infections, caused by organisms such as staphylococcus aureus, streptococcus pneumoniae, and enterococcus have an outer lipid cell membrane, and are a major cause of morbidity, mortality and cause complicated infections of many different tissues such as the skin, bloodstream, heart, lung, meninges, bone, and joints.

Nevakar has developed a proprietary and potentially safer and efficacious approach to overcome these life-threatening infections.

Our product is a novel formulation that has the potential to provide an improved pharmacokinetic profile, reduced nephrotoxicity and better antibiotic penetration to tissues that were previously difficult to treat.

Hospital Infections

Product CandidatesTherapeutic AreaResearchPreclinicalPhase IPhase IIPhase III
NVK-006Anti-infective
Research
Preclinical
Phase I
Phase II
Phase III